CASE REPORT |
|
Year : 2022 | Volume
: 8
| Issue : 1 | Page : 32-37 |
|
Pentoxifylline in the treatment of generalized granuloma annulare: A report of three cases
Vidya D Kharkar, Harish Balaji Rajendran, Anmol Bhargava
Department of Dermatology, Seth GS Medical College and KEM Hospital, Mumbai, Maharashtra, India
Correspondence Address:
Harish Balaji Rajendran Department of Dermatology, Seth GS Medical College and KEM Hospital, Mumbai, Maharashtra India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/ijdd.ijdd_15_21
|
|
Granuloma annulare (GA) is a benign self-limited granulomatous cutaneous disorder of unknown etiology. Clinical variants include localized, generalized, perforating, and subcutaneous. Generalized or disseminated GA is an uncommon variant displaying some clinical features that differentiate it from the localized form, including later age of onset, inadequate response to treatment, and less tendency to spontaneous resolution. The treatment modalities used for localized GA (topical or intralesional steroids, freezing with liquid nitrogen, or surgical excision) cannot be successfully applied to the large numbers of lesions seen in GA’s generalized form. Systemic treatments have included dapsone, chlorambucil, isotretinoin, systemic steroids, cyclosporine, salicylates, chloroquine, and PUVA. These treatments have potentially serious side effects in the long term and have not demonstrated consistent results. Literature overuse of pentoxifylline in the treatment of GA is limited. Here we report three prospective cases of generalized GA showing resolution with oral pentoxifylline. |
|
|
|
[FULL TEXT] [PDF]* |
|
 |
|